Latest filing published 05 Feb 2014 for Tvardi Therapeutics, Inc..
Insider track record
No signal scores available.
Charles Moller PhD: trading record in brief
All filings by Charles Moller PhD on record concern Tvardi Therapeutics, Inc. We count 2 filings, every one of them for a trade on 5 February 2014.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
On 5 February 2014 came the latest disclosure, a transaction in Tvardi Therapeutics, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Charles Moller PhD
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,068,704 shares0Common StockSEC:0001209191-14-007612:0
- 507,700 shares0Common StockSEC:0001209191-14-007612:1
2 of 2 declarations